Preparation and characterization of galactose-modified liposomes by a nonaqueous enzymatic reaction

被引:16
作者
Guo, Bo-Hong [2 ]
Cheng, Yi [1 ]
Lin, Lv-Ping
Lin, De-Hui
Wu, Wei
机构
[1] Guangzhou Univ Chinese Med, Dept Chinese Herbal Med, Guangzhou Higher Educ Mega Ctr, Guangzhou 510006, Guangdong, Peoples R China
[2] Guangdong Pharmaceut Univ, Dept Pharm, Guangzhou, Guangdong, Peoples R China
关键词
enzymatic synthesis; liposome; galactose; surface modification; glycyrrhetinic acid; GLYCYRRHETINIC ACID; DNA CARRIER; GLYCYRRHIZIN; LIVER; HEPATOCYTES; MECHANISM; POLYMERS; BINDING; DRUGS;
D O I
10.3109/08982104.2011.573795
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study, NOH (NOH = N-octadecyl-4-[(D-galactopyranosyl) oxy]-2,3,5,6-tetrahydroxy hexanamide) was enzymatically synthesized as a targeting molecule and incorporated into liposomes to prepare a liposome surface modified with galactose. Glycyrrhetinic-acid-loaded liposome (GA-LP) and glycyrrhetinic-acid-loaded liposome surface modified with galactose (NOH-GA-LP) were prepared by the ethanol-injection method. NOH-GA-LP was characterized by morphology, particle size, zeta potential, encapsulation efficiency, release in vitro, and stability. The size of spherical particles was in the range of 179-211 nm. Spherical particles exhibit a positive electrical charge (38.7 mV) and possess high encapsulation efficiency (91.3%) and show sustained release (72% over 48 hours) in vitro. This novel approach for the liposome surface modified with galactose by enzymatic synthesis is expected to provide potential application as a drug carrier for active targeted delivery to hepatocytes.
引用
收藏
页码:255 / 260
页数:6
相关论文
共 23 条
[1]   INTERFERON INDUCTION BY GLYCYRRHIZIN AND GLYCYRRHETINIC ACID IN MICE [J].
ABE, N ;
EBINA, T ;
ISHIDA, N .
MICROBIOLOGY AND IMMUNOLOGY, 1982, 26 (06) :535-539
[2]   Study of omeprazole-γ-cyclodextrin complexation in the solid state [J].
Arias, MJ ;
Moyano, JR ;
Muñoz, P ;
Ginés, JM ;
Justo, A ;
Giordano, F .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2000, 26 (03) :253-259
[3]   Preliminary study of different omeprazole-gamma-CD co-grinded systems [J].
AriasBlanco, MJ ;
Munoz, P ;
Moyano, JR ;
Gines, JM ;
Novak, C .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 143 (01) :113-118
[4]   SINGLE BILAYER LIPOSOMES PREPARED WITHOUT SONICATION [J].
BATZRI, S ;
KORN, ED .
BIOCHIMICA ET BIOPHYSICA ACTA, 1973, 298 (04) :1015-1019
[5]  
CONNOLLY DT, 1982, J BIOL CHEM, V257, P939
[6]   Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes [J].
Crosasso, P ;
Ceruti, M ;
Brusa, P ;
Arpicco, S ;
Dosio, F ;
Cattel, L .
JOURNAL OF CONTROLLED RELEASE, 2000, 63 (1-2) :19-30
[7]   Analysis of hepatic disposition of galactosylated cationic liposome/plasmid DNA complexes in perfused rat liver [J].
Fumoto, S ;
Nakadori, F ;
Kawakami, S ;
Nishikawa, M ;
Yamashita, F ;
Hashida, M .
PHARMACEUTICAL RESEARCH, 2003, 20 (09) :1452-1459
[8]   Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting [J].
Gao, SY ;
Chen, JN ;
Xu, XR ;
Ding, Z ;
Yang, YH ;
Hua, ZC ;
Zhang, JF .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 255 (1-2) :57-68
[9]   Controlled biodistribution of galactosylated liposomes and incorporated probucol in hepatocyte-selective drug targeting [J].
Hattori, Y ;
Kawakami, S ;
Yamashita, F ;
Hashida, M .
JOURNAL OF CONTROLLED RELEASE, 2000, 69 (03) :369-377
[10]   MECHANISM OF INHIBITORY EFFECT OF GLYCYRRHIZIN ON REPLICATION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) [J].
ITO, M ;
SATO, A ;
HIRABAYASHI, K ;
TANABE, F ;
SHIGETA, S ;
BABA, M ;
DECLERCQ, E ;
NAKASHIMA, H ;
YAMAMOTO, N .
ANTIVIRAL RESEARCH, 1988, 10 (06) :289-298